Summary
40 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $117.6M against $439.4K.
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 5.1% a year over the last 3 years.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 5.4% a year over 5 years. Over the last 3 years it fell by 5.1% a year. Earnings per share fell by 10% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $2.76M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High- Yield
- 18.81%
What do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product Sales and Supportive Services 93%
- Research and Development 6.9%
By region
- UNITED STATES 88%
- CANADA 5.8%
- Non-US 5.8%
Product Sales and Supportive Services brings in 93% of revenue.
Segments in detail